BioSpace News Archive

Ocugen is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases

- Application Seeks to Expand VRAYLAR Indication to Include the Treatment of Bipolar Depression

Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders

Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at the 2018 Cantor Global Healthcare Conference

Study enables clinical development in complement-mediated renal disorders

The new approximately 170,000 square foot facility will support more than 1,500 employees, including a state-of-the-art pharmacy facility, enhanced software and data science labs, and office space.

To Date, 61,000 Youth Educated Nationwide on Opioid Misuse and Abuse

Honoring its distinction as one of St. Jude Children’s Research Hospital’s longest-standing corporate partners and commitment to bettering the lives of all St. Jude patients, Kmart announced today a movement created in collaboration with St. Jude called Care to Dream.

CROP INFRASTRUCTRE CORP. (CSE: CROP) (OTC: CRXPF) announces that its subsidiary Elite Ventures Group LLC has signed a joint venture agreement with The Hempire LLC of Nevada (the “Tenant”) to purchase a 100% interest in an 1,000 acre Esmeralda County agricultural cannabis project tenanted with a suite of cannabis licenses including medical cultivation

French family-owned international healthcare group URGO and US Texas-based company SteadMed announce the merging of their North American medical activities, with Urgo Medical taking a majority stake in this strategic partnership, whose activities will focus on acute and chronic wounds.